Basophil activation test determination of CD63 combined with CD203c is not superior to CD203c alone in identifying ABPA in cystic fibrosis

Publication date: Available online 22 April 2016
Source:Journal of Allergy and Clinical Immunology
Author(s): Yael Gernez, Jeffrey Walters, Rabindra Tirouvanziam, Leonore A. Herzenberg, Richard B. Moss

Teaser

CD203c level at the surface of allergen-activated basophils is the best marker to identify allergic bronchopulmonary aspergillosis (ABPA) and discriminate from Aspergillus fumigatus colonization in patients with cystic fibrosis.


from #ENT via xlomafota13 on Inoreader http://ift.tt/1VHq0z9
via IFTTT